Searched for
CHINESE GROUP FOSUN
After AI, China unicorns are eyeing global domination in robotic humanoidsLinkerbot currently holds over 80 per cent of the global market share in high-degree-of-freedom (DoF) robotic hands.- Bay Capital launches digital fund, appoints Sandeep Barasia, Tej Kapoor as partnersBay Capital is launching a Digital Opportunities Fund to invest in public and private digital businesses in India. Sandeep Barasia and Tej ...
- Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
- 74% Chinese-owned Hyderabad pharma firm files for IPOThe fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.
- Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
- Fosun invests 800 crore in realty venture with Ahuja ConstructionsDeal is the first realty transaction in the country by a Chinese group
- China’s Fosun shifts focus on early-stage startups in IndiaThe investor, which has made a mix of mid-to-late-stage and public equity investments in India, has built a team to focus on early-stage st...
- Fosun targets Fortis: A white knight or a dark horse?Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many...
- China’s Fosun eyes stake in Ahuja ConstructionsThe Fosun Group is amongst China’s largest privately-owned investment conglomerates with interests spanning across pharmaceuticals, real es...
- Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
- Doklam effect? India said to block Fosun's $1.3 billion Gland purchaseThe companies haven’t been formally notified yet of the move, the people said, asking not to be identified because the information is priva...
- Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland PharmaThe deal with Fosun is also an example of the excellence of India’s manufacturing capabilities. It goes with the essence of the Make in Ind...
- Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
- China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
Load More
